Antonia Katsouda, Dimitrios Valakos, Vasilios S Dionellis, Sofia-Iris Bibli, Ioannis Akoumianakis, Sevasti Karaliota, Karim Zuhra, Ingrid Fleming, Noriyuki Nagahara, Sophia Havaki, Vassilis G Gorgoulis, Dimitris Thanos, Charalambos Antoniades, Csaba Szabo, Andreas Papapetropoulos
Journal of Experimental Medicine 2022 Jul 4;219(7):e20211894
DOI: 10.1084/jem.20211894View article 🡇
Funding
This research has been cofinanced by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH–CREATE—INNOVATE (project code: T2EΔK-00843; to A. Papapetropoulos), by the Hellenic Foundation for Research and Innovation (H.F.R.I.) under the “First Call for H.F.R.I. Research Projects to support Faculty members and Researchers and the procurement of high-cost research equipment grant” (project number: HFRI-FM17-886), by the Hellenic Institute for the Study of Sepsis (to A. Papapetropoulos), by the Hellenic State Scholarship Foundation IKY-Siemens Research Projects of Excellence (11/3056 to A. Papapetropoulos and A. Katsouda), by a scholarship to A. Katsouda by the Hellenic Foundation for Research and Innovation, by the Deutsche Forschungsgemeinschaft (CRC1366/1 B1 Project # 39404578 to I. Fleming and S.-I. Bibli, and the Cardio-Pulmonary Institute, EXC 2026, Project ID: 390649896), and by the Swiss National Research Foundation (SNSF 31003A_179434) to C. Szabo.
Keywords: mitochondrial; metabolism; obesity